Mitochondria, Metabolism, and Glutathione as Mediators of Cognitive Decline in Aging and Alzheimer’s Disease
2024
Mitochondria, Metabolism, and Glutathione in Cognitive Decline
Sample size: 91
publication
Author Information
Author(s): Mahapatra, Kumar, Sekhar, Taffet
Hypothesis
The mechanistic underpinnings of cognitive impairment in aging and Alzheimer's disease involve mitochondrial dysfunction and metabolic defects.
Conclusion
The symposium highlighted the role of glutathione deficiency and mitochondrial dysfunction in cognitive decline and discussed potential interventions.
Supporting Evidence
- Aging is a major risk factor for cognitive decline and Alzheimer's disease.
- Mitochondria are crucial for brain energy, and their dysfunction may lead to cognitive impairment.
- GlyNAC supplementation showed promise in reversing cognitive decline and metabolic defects.
Takeaway
As we get older, our brains can have trouble working well, and scientists are looking at how energy problems and certain nutrients might help fix that.
Methodology
The symposium included discussions on mitochondrial energetics, glucose metabolism, and GlyNAC supplementation in both animal models and human trials.
Participant Demographics
The study included 91 human participants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website